Overview
Type: Synthetic peptide
Form: Lyophilized powder
SERCA2 Blocking Peptide (#BLP-CP012) is the original antigen used for immunization during Anti-SERCA2 Antibody (#ACP-012) generation. The blocking peptide binds and ‘blocks’ Anti-SERCA2 primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
Applications: wb, ihc
For research purposes only. not for human use
Applications
Demonstration of Pre-adsorption control
Western blot analysis of rat heart membranes (lanes 1 and 5), mouse heart membranes (lanes 2 and 6), rat PC12 pheochromocytoma cell line lysate (lanes 3 and 7) and human Jurkat T cell leukemia cell line lysate (lanes 4 and 8):1-4. Anti-SERCA2 Antibody (#ACP-012), (1:200).
5-8. Anti-SERCA2 Antibody, preincubated with SERCA2 Blocking Peptide (#BLP-CP012).
Properties
Sequence
- CTPNKPSRTSMSK, corresponding to amino acid residues 498-510 of rat SERCA2 (Accession P11507).
Accession (Uniprot) Number P11507
Peptide Confirmation Confirmed by amino acid analysis and mass spectrometry.
Purity >70%
Storage Before Reconstitution Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
Reconstitution 100 µl double distilled water (DDW).
Storage After Reconstitution -20°C.
Antigen Preadsorption Control 1 µg peptide per 1 µg antibody.
Standard Quality Control Of Each Lot Western blot analysis.
